Minerva Neurosciences Inc (NERV)
NASDAQ: NERVHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 3.27 0.00%
NERV stock chart
Technical analysisKey statistics
All statistics- Market cap
- $156.13M
- EPS (TTM)
- -$36.12
- Dividend yield
- None
- 52-week range
- 2.24 – 12.46
- Day range
- 3.25 – 3.46
- Volume / Avg
- 106.47K / 185.38K
- Beta
- —
- Shares outstanding
- 47.75M
- Next earnings
- Nov 4, 2026
52-week range
NERV stock today
Minerva Neurosciences (NERV) closed at $3.27 on Oct 7, down 4.66% (-$0.16), versus the S&P 500's 0.22% decline. Shares are 73.8% below their 52-week high of $12.46, set on Oct 21, 2025 and 46.1% above the 52-week low of $2.24, near the bottom of the past year's range. NERV is down 18.7% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 50.0%.
Minerva Neurosciences has posted a net loss over the last twelve months (EPS of -$36.12), so its P/E ratio is not meaningful. Minerva Neurosciences's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Minerva Neurosciences
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2014
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $-0.14
Minerva Neurosciences peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CUECue Biopharma Inc. | 22.51 | -2.72% | $163.52M | vs NERV |
| NKTXNkarta Inc. | 2.27 | -1.73% | $162.59M | vs NERV |
| EMISEmmis Acquisition Corp. Class A | 10.27 | 0.00% | $162.02M | vs NERV |
| MSLESatellos Bioscience Inc. | 7.63 | +1.19% | $161.88M | vs NERV |
| PEPGPepGen Inc. | 2.40 | +3.90% | $166.01M | vs NERV |
| DERMJourney Medical Corporation | 5.95 | -3.41% | $167.94M | vs NERV |
| NBPNovaBridge Biosciences ADR | 1.37 | -2.14% | $158.92M | vs NERV |
| VRXAVeraxa Biotech AG | 1.20 | +11.11% | $169.69M | vs NERV |
Indexes, lists and sector
Largest Health Care stocks
Minerva Neurosciences stock FAQ
What is Minerva Neurosciences's stock price today?
NERV last traded at $3.27 as of Oct 7, 4:00 PM EDT, down 4.66% on the day. Prices are delayed at least 15 minutes.
Does Minerva Neurosciences pay a dividend?
No. Minerva Neurosciences does not currently pay a regular cash dividend.
When is Minerva Neurosciences's next earnings date?
Minerva Neurosciences is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $-0.14.
Has NERV ever split its stock?
Yes. The most recent NERV stock split was a 1-for-8 split on Jun 21, 2022.
What is the NERV 52-week high?
The 52-week high for NERV is $12.46 and the 52-week low is $2.24. The stock is currently 73.8% below its high.